A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.
Chen S, Nagel S, Schneider B, Dai H, Geffers R, Kaufmann M, Meyer C, Pommerenke C, Thress KS, Li J, Quentmeier H, Drexler HG, MacLeod RAF.
Chen S, et al. Among authors: li j.
Cell Oncol (Dordr). 2018 Feb;41(1):93-101. doi: 10.1007/s13402-017-0356-2. Epub 2017 Nov 8.
Cell Oncol (Dordr). 2018.
PMID: 29119387